CA Stock MarketDetailed Quotes
UDOC UniDoc Health Corp
- 0.380
- +0.030+8.57%
15min DelayMarket Closed Nov 29 15:59 ET
19.26MMarket Cap-5846P/E (TTM)
0.380High0.350Low18.50KVolume0.350Open0.350Pre Close6.95KTurnover0.98052wk High0.08%Turnover Ratio50.68MShares0.12752wk Low-0.065EPS TTM8.82MFloat Cap0.980Historical HighLossP/E (Static)23.21MShs Float0.127Historical Low-0.045EPS LYR8.57%Amplitude--Dividend TTM-10.86P/B1Lot Size--Div YieldTTM
UniDoc Health Corp Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -2,817.11%-2.29M | 25.90%-559.92K | 144.69%12.82K | -31.68%-141.64K | -13.97%-352.52K | 74.65%-78.58K | 68.33%-755.59K | 96.21%-28.67K | 89.97%-107.56K | 27.56%-309.31K |
| Net income from continuing operations | -169.61%-1.9M | -66.52%-2.26M | -84.98%-787.04K | -39.93%-325.15K | -53.42%-441.3K | -71.62%-706.36K | 54.84%-1.36M | 58.72%-425.48K | 79.55%-232.37K | 30.05%-287.64K |
| Operating gains losses | ---- | ---30.96K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -53.81%8.9K | 6.29%68.26K | -99.53%85 | 73.74%27K | 42.26%21.91K | 26.27%19.26K | 321.20%64.22K | 55.16%18.03K | 381.80%15.54K | 3,702.72%15.4K |
| Asset impairment expenditure | ---- | --73.73K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Remuneration paid in stock | -96.41%14.59K | --366.62K | ---13.77K | --0 | ---26.31K | --406.7K | --0 | --0 | --0 | --0 |
| Other non cashItems | -7.13%703 | 109.35%3.25K | --767 | --830 | --896 | --757 | ---34.74K | ---- | ---- | ---- |
| Change In working capital | -305.00%-412.17K | 113.12%1.22M | 86.20%770K | 36.47%155.68K | 320.34%92.29K | 133.04%201.06K | 148.06%571.99K | 57.09%413.53K | 136.55%114.08K | -158.27%-41.88K |
| -Change in receivables | -622.41%-99.84K | 318.44%47K | 951.77%100.68K | -1,484.42%-21.15K | 13.68%-18.71K | -203.79%-13.82K | 58.67%-21.52K | 49.78%-11.82K | -112.17%-1.34K | -196.35%-21.68K |
| -Change in inventory | ---- | ---32.35K | ---13.02K | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Change in prepaid assets | ---73.93K | -122.40%-20.02K | -36.53%53.61K | --1.58K | -4,246.09%-75.21K | --0 | 196.35%89.38K | -79.77%84.46K | --0 | --1.81K |
| -Change in payables and accrued expense | -210.95%-238.4K | 142.87%1.22M | 84.44%628.72K | 68.60%194.59K | 945.55%186.21K | 207.60%214.88K | 34.29%504.13K | 360.57%340.88K | -38.39%115.41K | -147.35%-22.02K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -2,817.11%-2.29M | 25.90%-559.92K | 144.69%12.82K | -31.68%-141.64K | -13.97%-352.52K | 74.65%-78.58K | 68.33%-755.59K | 96.34%-28.67K | 89.71%-107.56K | 27.56%-309.31K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -22.50%-62.77K | -639.16%-45.81K | ||||||
| Net PPE purchase and sale | ---- | --0 | --0 | ---- | ---- | ---- | -22.50%-62.77K | -639.16%-45.81K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | --0 | --0 | ---- | ---- | ---- | -22.50%-62.77K | -640.36%-45.81K | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 3,247.62%1.99M | 5,850.70%907.48K | 808.62%304.49K | 1,055.39%14.09K | 4,959.23%529.37K | 1,110.51%59.54K | -99.49%15.25K | -81.19%33.51K | -147.60%-1.48K | -197.97%-10.89K |
| Net issuance payments of debt | -219.32%-11.38K | -252.05%-23.19K | -133.24%-11.14K | -639.53%-10.91K | 1.96%-10.68K | 261.90%9.54K | 107.48%15.25K | 976.33%33.51K | ---1.48K | ---10.89K |
| Proceeds from stock option exercised by employees | 3,451.76%1.78M | --880.67K | --265.63K | --25K | --540.05K | --50K | --0 | --0 | --0 | --0 |
| Net other financing activities | --228.65K | --50K | --50.05K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 3,247.62%1.99M | 5,850.70%907.48K | 808.76%304.54K | 1,052.00%14.04K | 4,959.23%529.37K | 1,110.51%59.54K | -99.49%15.25K | -81.19%33.51K | -147.60%-1.48K | -197.97%-10.89K |
| Net cash flow | ||||||||||
| Beginning cash position | 677.21%398.89K | -93.99%51.32K | -11.60%81.58K | -4.20%209.13K | -94.01%32.28K | -93.99%51.32K | 203.16%854.43K | -93.58%92.29K | -91.45%218.29K | -81.86%538.49K |
| Current changes in cash | -1,471.23%-299.24K | 143.28%347.56K | 874.51%317.3K | -1.23%-127.54K | 155.23%176.85K | 93.97%-19.05K | -240.26%-803.11K | 92.99%-40.97K | 88.69%-125.99K | 23.00%-320.2K |
| End cash Position | 208.71%99.65K | 677.21%398.89K | 677.21%398.89K | -11.60%81.58K | -4.20%209.13K | -94.01%32.28K | -93.99%51.32K | -93.99%51.32K | -93.58%92.29K | -91.45%218.29K |
| Free cash from | -2,817.11%-2.29M | 31.58%-559.92K | 117.21%12.82K | -13.75%-141.64K | -13.97%-352.52K | 74.65%-78.58K | 66.42%-818.36K | 90.56%-74.48K | 88.58%-124.52K | 27.56%-309.31K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data